U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H5F3N2O2S
Molecular Weight 250.198
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of N-HYDROXYRILUZOLE

SMILES

ONC1=NC2=CC=C(OC(F)(F)F)C=C2S1

InChI

InChIKey=MFGRTKLVQQZZIE-UHFFFAOYSA-N
InChI=1S/C8H5F3N2O2S/c9-8(10,11)15-4-1-2-5-6(3-4)16-7(12-5)13-14/h1-3,14H,(H,12,13)

HIDE SMILES / InChI

Molecular Formula C8H5F3N2O2S
Molecular Weight 250.198
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 15:33:59 UTC 2023
Edited
by admin
on Sat Dec 16 15:33:59 UTC 2023
Record UNII
WMF9D045NF
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
N-HYDROXYRILUZOLE
Common Name English
N-HYDROXY-6-(TRIFLUOROMETHOXY)-2-BENZOTHIAZOLAMINE
Systematic Name English
N-HYDROXY METABOLITE OF RILUZOLE
Common Name English
2(3H)-BENZOTHIAZOLONE, 6-(TRIFLUOROMETHOXY)-, OXIME
Systematic Name English
2-BENZOTHIAZOLAMINE, N-HYDROXY-6-(TRIFLUOROMETHOXY)-
Systematic Name English
2-HYDROXYAMINO-6-(TRIFLUOROMETHOXY)BENZOTHIAZOLE
Systematic Name English
Code System Code Type Description
FDA UNII
WMF9D045NF
Created by admin on Sat Dec 16 15:33:59 UTC 2023 , Edited by admin on Sat Dec 16 15:33:59 UTC 2023
PRIMARY
PUBCHEM
9859774
Created by admin on Sat Dec 16 15:33:59 UTC 2023 , Edited by admin on Sat Dec 16 15:33:59 UTC 2023
PRIMARY
CAS
179070-90-7
Created by admin on Sat Dec 16 15:33:59 UTC 2023 , Edited by admin on Sat Dec 16 15:33:59 UTC 2023
PRIMARY
EPA CompTox
DTXSID80431979
Created by admin on Sat Dec 16 15:33:59 UTC 2023 , Edited by admin on Sat Dec 16 15:33:59 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> METABOLITE
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC Route of adminIstration
PHARMACOKINETIC
DOSE
PHARMACOKINETIC
Cmax PHARMACOKINETIC ROUTE OF ADMINISTRATION
PHARMACOKINETIC